Investigative Ophthalmology & Visual Science Cover Image for Volume 59, Issue 9
July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Baerveldt glaucoma drainage device induces diplopia and motility changes
Author Affiliations & Notes
  • Esma Islamaj
    Glaucoma, ROI - Rotterdam Eye Hospital, Rotterdam, Netherlands
  • Caroline P Jordaan-Kuip
    Rotterdam Ophthalmic Institute, Rotterdam Eye Hospital, Rotterdam, Netherlands
  • Koen A Vermeer
    Rotterdam Ophthalmic Institute, Rotterdam Eye Hospital, Rotterdam, Netherlands
  • Hans G Lemij
    Glaucoma, Rotterdam Eye Hospital, Rotterdam, Netherlands
    Rotterdam Ophthalmic Institute, Rotterdam Eye Hospital, Rotterdam, Netherlands
  • Peter WT De Waard
    Glaucoma, Rotterdam Eye Hospital, Rotterdam, Netherlands
  • Footnotes
    Commercial Relationships   Esma Islamaj, None; Caroline Jordaan-Kuip, None; Koen Vermeer, None; Hans Lemij, None; Peter De Waard, None
  • Footnotes
    Support  ZonMw,Topzorg projectnr 80-84200-98-14216
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2072. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Esma Islamaj, Caroline P Jordaan-Kuip, Koen A Vermeer, Hans G Lemij, Peter WT De Waard; Baerveldt glaucoma drainage device induces diplopia and motility changes. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2072.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Baerveldt drainage device Implantation (BGI) and trabeculectomy (TE) are both surgical procedures for lowering the intraocular pressure in the management of glaucoma. Diplopia may be a serious complication of BGI. The purpose of this study is to quantify any diplopia and motility changes after glaucoma surgery by BGI or TE.

Methods : We analyzed 51 patients with a BGI and 52 patients with a TE from a prospective cohort study at the Rotterdam Eye Hospital, the Netherlands. To quantify any diplopia, we asked patients about the presence of diplopia 1 year after surgery. When diplopia was present, the diplopia was defined as either gaze-evoked diplopia or diplopia in primary position and/or while reading. To quantify any ocular motility changes, we measured the ductions in 8 gaze directions with a synoptophore, both before surgery and 1 year postoperatively. We evaluated the patients’ ocular alignment with the patient fixating at 30 cm distance with the alternate prism cover test and with the patient fixating at distance with the synoptophore. The latter was also used to measure the fusion range.

Results : Significantly more patients experienced diplopia in the BGI group than in the TE group (p<0.001, Fisher’s exact test). In the BGI group, 6 patients experienced gaze-evoked diplopia and 8 patients had diplopia in primary position and/or while reading. By contrast, only 1 TE patient experienced diplopia. The duction restrictions of the operated eye in the BGI group, compared to the TE group, were statistically significant in abduction (p = 0.02; Man Whitney U-test), in elevation (p = 0.002) and in elevation in 25oabduction (p = 0.005). Not surprisingly, all 6 BGI patients with gaze-evoked diplopia had a duction reduction (fig. 1). 6 of the 8 BGI patients with diplopia in primary position and/or while reading had an ocular alignment outside their fusion range (fig. 2). The fusion range was not sufficient to correct the deviation in their ocular alignment, which might explain their diplopia.

Conclusions : BGI surgery was significantly associated with diplopia and reduced duction. The duction reduction was mostly present in gaze directions towards the location of the implant, superotemporally, which can lead to experiencing diplopia. Further research is now required to determine the underlying cause of diplopia in patients with a BGI. Understanding the mechanism may lead to novel methods to reduce the diplopia risk after BGI.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×